Haematologica (May 2024)
Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia
- Amber Gibson,
- Cesar Nunez,
- Lindsay Robusto,
- Brianna Kammerer,
- Miriam Garcia,
- Michael Roth,
- Rachna Sheth,
- Priti Tewari,
- Aline Hittle,
- Laurie Toepfer,
- Romeo Torres,
- Nicholas J. Short,
- Elias Jabbour,
- Nitin Jain,
- Branko Cuglievan,
- David McCall
Affiliations
- Amber Gibson
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Cesar Nunez
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Lindsay Robusto
- Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston TX
- Brianna Kammerer
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Miriam Garcia
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Michael Roth
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Rachna Sheth
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Priti Tewari
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Aline Hittle
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Laurie Toepfer
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Romeo Torres
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- Nicholas J. Short
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
- Elias Jabbour
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
- Nitin Jain
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
- Branko Cuglievan
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- David McCall
- Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
- DOI
- https://doi.org/10.3324/haematol.2023.284950
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
